Nastech Pharmaceuticals has reported that revenue for the three months ended December 31, 2007 was $6.4 million, compared to $4.8 million for the quarter ended December 31, 2006.
Subscribe to our email newsletter
Revenue for the year ended December 31, 2007 was $18.1 million, compared to $28.5 million for the year ended December 31, 2006. Net loss for the three months ended December 31, 2007 was $12 million or $0.47 per share, as compared to a net loss of $10.7 million, or $0.50 per share for the same period of 2006.
The net loss for the year ended December 31, 2007 was $52.4 million or $2.10 per share, as compared to $26.9 million, or $1.27 per share, for the corresponding period of 2006.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.